6-Methoxypurine-9-beta-D- (3-methoxy riboside)

6-Methoxypurine-9-beta-D- (3-methoxy riboside), a purine nucleoside analog, exhibits extensive antitumor effects, particularly against indolent lymphoid malignancies. Its anticancer mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, among others [1].